Beneficient announced that on October 29, 2025, it was notified by The Nasdaq Stock Market, LLC that the company had regained compliance with two critical listing requirements. This includes the Nasdaq periodic reporting requirement, achieved by filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.
The company also regained compliance with the Nasdaq minimum $35 million market value of listed securities requirement, which serves as an alternative to Nasdaq’s minimum stockholders’ equity requirement. These resolutions address significant concerns that had led to previous delisting notices.
Despite these positive developments, Beneficient remains noncompliant with the $1.00 per share bid price requirement. The company must regain compliance within the extension period granted by the Nasdaq Hearings Panel to avoid delisting and plans to seek stockholder approval for a reverse stock split if necessary.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.